MedPath
TGA Approval

PHENTERMINE LAPL phentermine 40 mg sustained release capsule blister pack (304020)

304020

PHENTERMINE LAPL phentermine 40 mg sustained release capsule blister pack

Lupin Australia Pty Limited

May 4, 2020

Medicine

Medicine

Active

Registered

Active Ingredients

phentermine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

PHENTERMINE LAPL phentermine 40 mg sustained release capsule blister pack (304020) - TGA 批准文号 | MedPath